Large-scale testing (Phase 3)Study completedNCT00683878What this trial is testingAdd-on to Thiazolidinedione (TZD) FailuresWho this might be right forType 2 Diabetes AstraZeneca 972
Large-scale testing (Phase 3)Study completedNCT00313313What this trial is testingSaxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasWho this might be right forDiabetes AstraZeneca 768
Large-scale testing (Phase 3)Study completedNCT01708902What this trial is testingStudy to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 876
Large-scale testing (Phase 3)Study completedNCT00121641What this trial is testingSaxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseWho this might be right forDiabetes Mellitus, Type 2 AstraZeneca 1,035
Post-approval studies (Phase 4)Study completedNCT02027753What this trial is testingEfficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor TherapyWho this might be right forDiabetes Mellitus, Type 2 Sanofi 109
Large-scale testing (Phase 3)Study completedNCT01087502What this trial is testingSafety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal ImpairmentWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT01333592What this trial is testingLong-term Study of KAD-1229 in Type 2 Diabetes PatientsWho this might be right forType 2 Diabetes Kissei Pharmaceutical Co., Ltd. 136
Post-approval studies (Phase 4)UnknownNCT02426294What this trial is testingComparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus AlogliptinWho this might be right forType 2 Diabetes Mellitus Pusan National University Hospital 154
Large-scale testing (Phase 3)Study completedNCT01462266What this trial is testingStudy of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 660
Large-scale testing (Phase 3)Study completedNCT01215097What this trial is testingEfficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin TherapyWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 306
Post-approval studies (Phase 4)Study completedNCT00832390What this trial is testingStudy to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)Who this might be right forDiabetes Mellitus Merck Sharp & Dohme LLC 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07417306What this trial is testingHDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorWho this might be right forType 2 Diabetes Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 912
Large-scale testing (Phase 3)Study completedNCT00654381What this trial is testingJapanese P III vs Voglibose and PlaceboWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 561
Testing effectiveness (Phase 2)Study completedNCT01046422What this trial is testingSafety Study of BMS-770767 in Subjects With Type 2 DiabetesWho this might be right forDiabetes Type 2 Bristol-Myers Squibb 76
Large-scale testing (Phase 3)Study completedNCT01034111What this trial is testingA Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)Who this might be right forType 2 Diabetes Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Study completedNCT06739044What this trial is testingEfficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 494
Large-scale testing (Phase 3)Study completedNCT01947855What this trial is testingPost Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 60
Large-scale testing (Phase 3)Study completedNCT00875394What this trial is testingStudy to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)Who this might be right forDiabetes Mellitus, Non-Insulin-Dependent Merck Sharp & Dohme LLC 68
Large-scale testing (Phase 3)Study completedNCT00996658What this trial is testingLinagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With PioglitazoneWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 278
Large-scale testing (Phase 3)UnknownNCT04255238What this trial is testingEvaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin AloneWho this might be right forDiabetes Mellitus, Type 2 LG Chem 468